Found 38 matching trials
Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer. PHASE2 This study is being done to test the safety and effectiveness of two drugs,...
Show More Location
University of Kansas Medical Center
Learn More & Join Trial
Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer PHASE3 RATIONALE: Hormones can stimulate the growth of prostate cancer cells. Horm...
Show More Location
Cross Cancer Institute
Learn More & Join Trial
Oral Anti Diabetic Agents in the Hospital PHASE4 This randomized controlled clinical trial will assess whether continuation ...
Show More Status
Active Not Recruiting
Location
Emory University Hospital Midtown
Learn More & Join Trial
DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Breast Cancer Patients N/A This study is being done to determine if there is a pattern associated with...
Show More Location
Mayo Clinic in Florida
Learn More & Join Trial
Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer PHASE1 The purpose of this study is to evaluate the safety, tolerability and preli...
Show More Location
Yale New Haven Hospital
Learn More & Join Trial
A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer) PHASE3 This Phase III, randomized, two-arm, open-label, multicenter study will eva...
Show More Status
Active Not Recruiting
Location
Arizona Clinical Research Center, Inc
Learn More & Join Trial
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer PHASE3 This study will evaluate the efficacy and safety of inavolisib in combinati...
Show More Location
Banner Health MD Anderson AZ
Learn More & Join Trial
PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA) PHASE2 The goal of this research study is to compare a combination of two drugs, c...
Show More Location
Dana-Farber Cancer Institute
Learn More & Join Trial
Omission of Adjuvant Radiotherapy in Young Low-Risk Ductal Carcinoma In Situ Following Breast-Conserving Surgery PHASE2 This is a single-center, prospective phase II clinical study designed to ev...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Health-Related Quality of Life Coupled With Therapeutic Information on Compliance to Endocrine Therapy in Breast Cancer NA Only 59% of women with breast cancer (BC) treated with Endocrine Therapy (E...
Show More Location
Centre Georges François Leclerc
Learn More & Join Trial